Medical Science News

RSS
The emergence and spread of the SARS-CoV-2 Lambda (B.1.621) variant

The emergence and spread of the SARS-CoV-2 Lambda (B.1.621) variant

New study identifies novel compound as promising pan-coronavirus drug candidate

New study identifies novel compound as promising pan-coronavirus drug candidate

New study reveals unique immune responses to SARS-CoV-2, Ebola and respiratory syncytial virus using B cell repertoire analysis

New study reveals unique immune responses to SARS-CoV-2, Ebola and respiratory syncytial virus using B cell repertoire analysis

Study uses computational modeling of coronavirus spike proteins to examine dynamics responsible for immunogenicity and immune escape

Study uses computational modeling of coronavirus spike proteins to examine dynamics responsible for immunogenicity and immune escape

Researchers use residues in wastewater to study illicit drug consumption

Researchers use residues in wastewater to study illicit drug consumption

Visual imagination motivates people to engage in pleasurable and achievement-oriented activities

Visual imagination motivates people to engage in pleasurable and achievement-oriented activities

People’s perceptions of sexual orientation can change after reading informational articles, study suggests

People’s perceptions of sexual orientation can change after reading informational articles, study suggests

Nanotechnology provides novel solutions against zoonotic viruses

Nanotechnology provides novel solutions against zoonotic viruses

Human milk oligosaccharides may help treat or prevent bacterial infections in newborns and adults

Human milk oligosaccharides may help treat or prevent bacterial infections in newborns and adults

DeepSARS simultaneously detects and conducts genomic surveillance of SARS-CoV-2

DeepSARS simultaneously detects and conducts genomic surveillance of SARS-CoV-2

New prediction model can identify NSCLC patients who are not likely to respond to immunotherapy

New prediction model can identify NSCLC patients who are not likely to respond to immunotherapy

Leducq Foundation awards $7 million for vascular malformation research

Leducq Foundation awards $7 million for vascular malformation research

TU Dresden scientists develop implantable AI platform for real-time biosignal classification

TU Dresden scientists develop implantable AI platform for real-time biosignal classification

New antibody found to be highly protective against wide range of COVID-19 virus variants

New antibody found to be highly protective against wide range of COVID-19 virus variants

Over-the-counter acid reflux drug appears to improve the odds of survival for COVID-19 patients

Over-the-counter acid reflux drug appears to improve the odds of survival for COVID-19 patients

Isometric resistance training could have a strong effect on reducing blood pressure

Isometric resistance training could have a strong effect on reducing blood pressure

A systematic review of in vitro studies evaluating the efficacy of mouth rinses on SARS-CoV-2

A systematic review of in vitro studies evaluating the efficacy of mouth rinses on SARS-CoV-2

3D-printed tumors potentially next step in personalized medicine

3D-printed tumors potentially next step in personalized medicine

SARS-CoV-2 mutations alter dynamics of neutralizing antibodies

SARS-CoV-2 mutations alter dynamics of neutralizing antibodies

SARS-CoV-2 lambda variant escapes immune response via spike mutations

SARS-CoV-2 lambda variant escapes immune response via spike mutations

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.